<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU style='word-wrap:break-word'>

<div class=WordSection1>

<h1><span lang=EN-US>Myasthaenia Gravis</span></h1>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Disease:</span></h2>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Pathophysiology</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>IgG antibodies against skeletal muscle nAChR,
  produced by abnormal immune response</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Average 30% of normal number of nAChR</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Very few spare receptors</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Presentation</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Women in their 20s, men in their 60s</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Fatigueable weakness</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Normal tendon reflexes</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oculobulbar commonest (diplopia, ptosis)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Craniocaudal spread</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Myaesthaenic crisis (diaphragm) most likely
  during first 2 years</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>With use: brief potentiation then fade</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Severity</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US>Ocular only</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US>Ocular + mild other</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US>Ocular + moderate other</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US>Ocular + severe other</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US>Intubation +/- IPPV</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span lang=EN-US>Subtypes
  for grades 2,3,4 – limb vs trunk vs resp muscles</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Associated</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Rheumatoid arthritis</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Thyroid disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Test</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Edrophonium test: 10mg IV effective within 30
  seconds, lasts 5 minutes (negative result does not exclude dx)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>EMG: reduced compound muscle action potential
  (CMAP) amplitude i.e. fade!</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Blood test: anti-nAChR antibody</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Treatment</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Anticholinesterase (note risk of cholinergic
  crisis cf. myasthaenic crisis)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Antibody removal: IVIg, plasma exchange</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Immunosuppression: prednisolone, azathioprine</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Thymectomy</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Myasthaenia gravis vs Eaton-Lambert</span></h2>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><b><span
  lang=EN-US>ELMS</span></b></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><b><span
  lang=EN-US>MG</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Aetiology</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Cancer (esp. SCLC)</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>T cell-mediated<br>
  (thymoma 10-15%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Pathophysiology</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Auto-antibody against pre-synaptic VDCC</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Auto-antibody against muscle type nAChR</span></p>
  </td>
 </tr>
 <tr>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Presentation</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Limb weakness (prox LL)</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Symmetrical</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Deterioration with use</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Reduced tendon reflexes</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>PSNS dysfunction</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Ocular, bulbar, facial weakness</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Asymmetrical</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Initial improvement with use</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Normal tendon reflexes</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Normal autonomic function</span></p>
  </td>
 </tr>
 <tr>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Time course</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Fluctuation</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Gradual onset</span></p>
  </td>
 </tr>
 <tr>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Testing</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Reduced CMAP amplitude</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Normal CMAP amplitude</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Edrophonium test (Tensilon)</span></p>
  </td>
 </tr>
 <tr>
  <td width=200 valign=top style='width:150.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Treatment</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Immunosuppression</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Guanidine</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>3,4-diaminopyridine</span></p>
  </td>
  <td width=200 valign=top style='width:150.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Immunosuppression</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Anticholinesterase</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Thymectomy</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Pre-op issues:</span></h2>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Location</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Must have ICU available for prolonged
  intubation + IPPV</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Assessment</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Peri-op/neurology review</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Respiratory function tests if possible</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Risk stratification: Leventhal criteria </span><span
  lang=EN-US>±</span><span lang=EN-US> refer to HDU/ICU</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Optimisation</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Medication planning:</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.55pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Consider glucocorticoid, IVIg</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.55pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Withhold anticholinesterase on morning of
  surgery</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Chest physio</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Risk stratification</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Leventhal criteria: more likely prolonged ventilation if:</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Severe disease (3 or 4)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Longstanding disease (&gt;6 years)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Poor respiratory function (FVC &lt;3L)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Other respiratory disease</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US>Intra-op issues:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Mode</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Prefer regional</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Airway</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Beware bulbar weakness -&gt; risk of aspiration</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Beware associated rheumatoid arthritis -&gt;
  risk of C spine injury</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Breathing</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Prefer spont vent</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Circulation</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Nothing in particular</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Drugs</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Avoid muscle relaxant</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.55pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Prefer rocuronium + sugammadex</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.55pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Resistant to suxamethonium</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.55pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Resistant to non-depolarising drugs</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Avoid volatiles</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Avoid excessive opioid; prefer non-opioids +
  neuraxial/regional</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Give anticholinesterase + antimuscarinic
  pre-extubation</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Monitoring</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>TOF: but how to interpret.</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US>Post-op:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Extubation</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Awake ++</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Reversal ++</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:105.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Monitoring</span></p>
  </td>
  <td width=460 valign=top style='width:344.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Expect high rate of failure if abdominal or
  thoracic surgery</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Observe for longer than usual after extubation
  and in PACU</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.3pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Low threshold for HDU</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h1><span lang=EN-US>2014-2-9 A 30 year old patient with myasthenia gravis
presents for orthopaedic procedure and refuses a regional anaesthetic technique<br>
a. What are the signs and symptoms of myasthenia gravis? (30%)<br>
b. How does the disease aﬀect your anaesthetic management? (70%</span></h1>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><i><span lang=EN-US>Examiner’s
report:</span></i></p>

<p class=MsoNormal style='margin-bottom:0cm'><i><span lang=EN-US>Key components
of a basic answer for this question: Knowledge that is a disease of skeletal
muscle manifest by fatigability and that both bulbar and respiratory muscles
can be effected. A structured plan for anaesthetic management that
acknowledges   Aspiration risk  Sensitivities to opiates and muscle relaxants 
And includes a reasonable plan for post-operative management A plan for the management
of the patients anticholinesterase therapy [and  steroids if applicable ] in
the perioperative period</span></i></p>

<p class=MsoNormal style='margin-bottom:0cm'><i><span lang=EN-US>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>a.Signs and
symptoms: see above</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>b.Anaesthetic
management</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>Pre-op:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>See above r.e. assessment and optimisation</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Explore reason for refusal of regional</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Discuss spinal + midazolam sedation</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Discuss adductor canal block/catheter under GA
at end of case</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>Intra-op:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Anaesthetic: propofol + remifentanil GA
(minimize remi, use others for analgesia)</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Airway: LMA if fasted and low aspiration risk. Beware
rheumatoid arthritic C-spine, consider video laryngscopy.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Breathing: pressure supported breaths to avoid
diaphragm weakness (occurs from 30 mins of apnoea)</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Circulation: no problem really</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Treatment drugs: consider stress dose corticosteroid
e.g. hydrocortisone 50mg TDS</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analgesics: adductor canal catheter under GA,
bolus 20mL 0.2% ropivacaine + paracetamol + NSAID + fentanyl 0.5mcg/kg PRN + ketamine
bolus 0.5mg/kg and infusion 0.1-0.2mg/kg/h; paracetamol 15mg/kg; NSAID (if
allowed); fentanyl boluses 0.5mcg/kg PRN</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Other drugs: avoid volatile, avoid paralysis</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>NMBD: avoid paralysis altogether; avoid sux
(resistant), half dose roc 0.3mg/kg (sensitive), sugammadex for reversal</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>Post-op:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analgesia: paracetamol + NSAID + oxycodone
0.1-0.2mg/kg q3h prn +/- adductor canal catheter 0.2% ropiv 6mL/h (to be
removed day 2 post-op) +/- ketamine IV infusion 0.1-0.2mg/kg/h<br>
(I believe preferable to PCA because a) very painful surgery b) reduces opioid
requirement c) gut function is intact</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Longer stay in PACU</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Follow-up: APS review daily</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h1><span lang=EN-US>2006-1-5 A ﬁfty year old man taking corticosteroid and
pyridostigmine for myasthenia gravis is to have an elective right hemicolectomy
under general anaesthesia. Discuss your management of his myasthenia pre and
post operatively.</span></h1>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><i><span lang=EN-US>Examiner’s
report:</span></i></p>

<p class=MsoNormal style='margin-bottom:0cm'><i><span lang=EN-US>This question
dealt with the uncommon but important topic of myasthenia gravis.  The
principal concerns from an anaesthetist’s standpoint are the degree of
respiratory dysfunction present, the increased risk of aspiration, the altered
doses of neuromuscular relaxants required, the timing of extubation
post-operatively and the ongoing need to ensure adequate muscle power.  Most
candidates were aware of the preoperative Leventhal criteria that are
predictive of the need for postoperative ventilation but relatively few were
able to coherently discuss the other important clinical aspects of this disease
that need to be addressed before providing anaesthesia.  A significant minority
of candidates did not appear to appreciate the factors involved in deciding
when and where to extubate these patients, nor the continuing aspects of
clinical care involved in their postoperative management.  A description of how
to conduct the actual anaesthetic was not required nor expected.</span></i></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>Pre-op:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>See above</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Plan ICU/HDU admission post-op for resp
monitoring</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>Intra-op:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Anaesthetic: propofol GA (avoid volatile)</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Airway: ETT, consider RSI if aspiration risk.
Beware rheumatoid arthritic C-spine, consider video laryngoscopy.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Breathing: paralysis + IPPV required</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Circulation: less likely a problem</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Treatment drugs: take AChEi pre-op; consider
IVIG pre-op; stress corticosteroid e.g. hydrocortisone 50mg TDS</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analgesics: paracetamol + fentanyl 0.5mcg/kg PRN
+ (if large midline laparotomy) ketamine IV infusion 0.1-0.2mg/kg/h; wound
infiltration catheter inserted at closure</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>NMBD: avoid paralysis altogether; avoid sux
(resistant), half dose roc 0.3mg/kg (sensitive), sugammadex for reversal; TOF
monitoring</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>Post-op:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Attempt extubation in OR: airway suctioned,
sugammadex reversal for TOF ratio &gt;0.9, sitting up, pressure support 10/5cmH<sub>2</sub>O,
obeying commands</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Communicate re-intubation plan to assistant</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>If failed, then transfer to ICU for slower
extubation</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>If success, then longer stay in PACU before transfer
to HDU</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analgesia: wound infiltration catheter 0.2%
ropivacaine 20mL bolus + 6mL/h; to be removed at day 3-5</span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Follow-up: APS review daily</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>
